U.S. Logistics Stock News

NYSE:ENVA
NYSE:ENVAConsumer Finance

Enova International Expands Digital Lending Reach With Grasshopper Bancorp Acquisition

Enova International (NYSE:ENVA) announces an agreement to acquire Grasshopper Bancorp, Inc. The transaction adds a digital bank platform to Enova's existing fintech and online lending operations. The deal is expected to expand Enova's reach with small business and digitally focused customers. For investors, this move connects Enova International's consumer and small business lending focus with a full digital banking platform at Grasshopper Bancorp, Inc. NYSE:ENVA is already rooted in online...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Is It Too Late To Consider Coca-Cola Consolidated (COKE) After A Powerful Multi‑Year Rally

If you are wondering whether Coca-Cola Consolidated is still reasonably priced after a strong run, this article will walk through what the current share price might be implying about its value. The stock recently closed at US$195.20, with returns of 17.5% over 7 days, 30.0% over 30 days, 30.3% year to date and 41.2% over 1 year. The 3 year return is 262.7% and the 5 year return is roughly 7x the earlier level. Recent news around Coca-Cola Consolidated has largely focused on its position...
NasdaqGM:LRMR
NasdaqGM:LRMRBiotechs

Larimar Therapeutics (LRMR) Valuation After FDA Breakthrough Therapy Designation For Nomlabofusp

FDA milestones put Larimar Therapeutics (LRMR) and nomlabofusp in sharper focus Larimar Therapeutics (LRMR) is back on investors’ radar after the FDA granted Breakthrough Therapy Designation to its Friedreich's ataxia candidate nomlabofusp and signaled openness to a surrogate endpoint supporting a potential accelerated approval filing. See our latest analysis for Larimar Therapeutics. The FDA update has arrived alongside a sharp pickup in momentum, with a 1 day share price return of 31.32%...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Is Veracyte (VCYT) Pricing Reflect Its Genomic Diagnostics Role After Recent Share Price Weakness

If you are wondering whether Veracyte shares are attractively priced right now, you are not alone. This article is built to help you think clearly about what you are paying for. The stock closed at US$35.69, with returns of a 0.9% decline over 7 days, a 15.6% decline over 30 days, a 15.8% decline year to date and a 6.7% decline over 1 year, while the 3 year return sits at 45.0% and the 5 year return at a 42.6% decline. Recent news coverage has focused on Veracyte's position in genomic...
NYSE:ALSN
NYSE:ALSNMachinery

Is It Too Late To Reassess Allison Transmission (ALSN) After Its Strong Multi Year Run?

If you are wondering whether Allison Transmission Holdings is still fairly priced after its strong run, this article will walk through what the current share price might be implying about value. The stock last closed at US$121.99, with returns of 3.9% over 7 days, 11.3% over 30 days, 23.3% year to date and 24.2% over the past year. The 3 year and 5 year returns are very large at about 1.7x and 2.3x respectively. Recent coverage has focused on Allison Transmission Holdings as a long term...
NYSE:MCK
NYSE:MCKHealthcare

McKesson Board Investigation Puts 2013 Stock Plan Dilution Under Scrutiny

A law firm has opened an investigation into McKesson's Board of Directors over potential breaches of fiduciary duty tied to a 2013 stock incentive plan. The review focuses on the Board's recommendation that shareholders approve issuing a substantial number of additional shares and the possible dilutive effect on existing holders. The inquiry centers on whether the Board acted in the best interests of shareholders when it supported the expanded stock issuance. For investors in McKesson,...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics Q4 Loss Narrows To US$0.18 EPS And Tests Bearish Narratives

Iovance Biotherapeutics (IOVA) closed out FY 2025 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.18, alongside a quarterly net loss of US$71.9 million. The company has seen quarterly revenue move from US$73.7 million in Q4 2024 to US$86.8 million in Q4 2025, while basic EPS shifted from a loss of US$0.26 to a loss of US$0.18 over the same period, setting up a results season where investors are weighing growing sales against ongoing losses. With trailing twelve...
NasdaqGS:RXT
NasdaqGS:RXTIT

A Look At Rackspace Technology (RXT) Valuation After The Palantir AI Partnership And Rapid Share Price Rally

Rackspace Technology (RXT) has quickly moved onto many investors’ radars after announcing a partnership with Palantir Technologies that positions the company as a managed services provider for Palantir’s data and AI platforms. See our latest analysis for Rackspace Technology. The Palantir announcement has coincided with a sharp shift in sentiment, with a 7 day share price return of 248.45% and a 30 day share price return of 82.07%. However, the 1 year total shareholder return of 43.41% and 5...
NasdaqGS:CLNE
NasdaqGS:CLNEOil and Gas

How Amazon Warrant-Driven Loss Outlook At Clean Energy Fuels (CLNE) Has Changed Its Investment Story

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...
NYSE:LNN
NYSE:LNNMachinery

Lindsay Expands Roadway Safety Lineup With New Products And Growth Aims

Lindsay (NYSE:LNN) has introduced two new safety products, the Road Runner Truck-Mounted Attenuator and the AlphaGuard Channelizing Device. The products expand the company’s roadway and work zone safety lineup, targeting construction and traffic management applications. Both launches focus on work zone protection, operational efficiency, and evolving infrastructure management needs. Lindsay, trading at $135.74, is building on its position in roadway and infrastructure safety with these new...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Revenue Ramp To US$38 Million Tests Profitability Optimism

ImmunityBio FY 2025 earnings snapshot ImmunityBio (IBRX) has reported its FY 2025 results with Q4 revenue of US$38.3 million and a basic EPS loss of US$0.06, alongside net income loss excluding extra items of US$61.9 million. This puts the focus squarely on how quickly the business can scale to cover its cost base. The company has seen quarterly revenue move from US$7.6 million in Q4 2024 to US$16.5 million in Q1 2025, US$26.4 million in Q2 2025, US$32.1 million in Q3 2025 and US$38.3 million...
NYSE:INVH
NYSE:INVHResidential REITs

Is It Time To Reconsider Invitation Homes (INVH) After Its Recent Share Price Slide

If you are wondering whether Invitation Homes is starting to look like value at its current share price, this article will walk through what the numbers actually say about that question. The stock closed at US$25.67, with returns of 5.4% decline over 7 days, 5.6% decline over 30 days, 7.4% decline year to date, 16.9% decline over 1 year, 9.0% decline over 3 years and 1.6% gain over 5 years. These figures may have some investors reassessing both the potential upside and the risks. Recent...
NasdaqGS:PICS
NasdaqGS:PICSDiversified Financial

Is It Too Late To Reconsider PicS (PICS) After The Recent 27% Price Jump

If you are wondering whether PicS is attractively priced at its recent levels, this article will walk through what the current numbers are really saying about the stock. The share price recently closed at US$16.81, with a 7 day return of 27.4% and a year to date return of an 11.5% decline. This has caught the attention of investors who are considering the balance between growth potential and risk. Recent news coverage around PicS has focused on its positioning within the diversified...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Match Group Board Exits Raise Questions On Future Oversight And Strategy

Pamela Seymon and former CEO Sharmistha Dubey plan to leave Match Group's Board at the 2026 Annual Meeting. The departures will change the board composition at NasdaqGS:MTCH and affect its governance structure. Investors are watching for how these board changes may influence oversight and long term company direction. Match Group, the parent of several online dating platforms, sits at the center of how people form relationships through digital services. As user behavior, regulation, and...
NYSE:MLM
NYSE:MLMBasic Materials

Martin Marietta Quikrete Deal Deepens Aggregates Focus And Tests Profit Outlook

Martin Marietta Materials (NYSE:MLM) has closed an asset exchange with Quikrete Holdings involving aggregates, cement, ready-mix, and nonoperating land assets. The deal shifts NYSE:MLM further toward an aggregates-led product mix and adds cash to the balance sheet. The transaction covers operations in multiple regions and is described by the company as a key part of its SOAR 2025 plan. Management frames the exchange as a step toward greater earnings durability, added financial flexibility,...
NYSE:UHAL
NYSE:UHALTransportation

How Investors May Respond To U-Haul (UHAL) Slashing 2027 Truck Purchases To Tackle Fleet Imbalances

In the past week, U-Haul Holding Company reported its 3Q FY2026 results, with total revenues rising 1.9% as self-storage revenue increased 7.9%, while higher depreciation and losses on retired rental equipment, particularly cargo vans, reduced earnings per share by US$0.24. An important takeaway is management’s plan to cut more than US$500,000,000 in truck purchases for fiscal 2027 and expand its dealer network to address fleet imbalances and sharpen the core moving and storage...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

Has QuidelOrtho (QDEL) Become A Potential Opportunity After Its Sharp Share Price Slide

If you are wondering whether QuidelOrtho is starting to look like a value opportunity or a value trap, its current share price means it is a stock where valuation really matters. The share price closed at US$21.93, with a 5.2% decline over 7 days, a 21.9% decline over 30 days, a 23.8% decline year to date and a 46.8% decline over the past year, while the 3-year and 5-year returns stand at a 74.8% decline and an 86.4% decline respectively. Recent news coverage has focused on QuidelOrtho's...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Lawsuits Put Relacorilant Setback And Investor Risk In Focus

Multiple shareholder class action lawsuits have been filed against Corcept Therapeutics (NasdaqCM:CORT) after the company disclosed that the FDA issued a Complete Response Letter for relacorilant. Plaintiffs allege Corcept and certain executives misrepresented FDA communications and the likelihood of approval for relacorilant prior to the New Drug Application decision. The lawsuits claim that longstanding regulatory concerns about the clinical evidence for relacorilant were not adequately...
NYSE:SEM
NYSE:SEMHealthcare

Select Medical Take Private Interest Spurs Fresh Look At Valuation Risks

Select Medical Holdings (NYSE:SEM) has received a nonbinding indication of interest to take the company private. A special committee of the Board is currently reviewing the proposal. The approach represents a potential change in ownership structure and corporate control. For shareholders, the timing of this approach comes after a mixed share price record. The stock closed at $14.82, with a 1-year return of a 21.3% decline and a 3-year return of a 6.6% decline. Over 5 years, the share price...
NYSE:AWR
NYSE:AWRWater Utilities

American States Water Keeps ATM Capacity As Funding And Dilution Questions Linger

American States Water (NYSE:AWR) has amended its Equity Distribution Agreement for its at the market equity offering program. Under the amendment, Huntington Securities replaces Janney Montgomery Scott as one of the sales agents. The company still has a significant portion of its authorized shares available for potential issuance under the program. American States Water is a regulated water utility and services provider, so access to cost effective equity funding can matter for long term...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Did Columbia Banking System's (COLB) Dividend Affirmation Quietly Reframe Its Capital Allocation Story?

Earlier this month, Columbia Banking System, Inc. declared a quarterly cash dividend of US$0.37 per common share, payable on March 16, 2026, to shareholders of record as of February 27, 2026. This dividend affirmation, alongside revenue growth of approximately 23.2% as of December 31, 2025 relative to peers, highlights management’s confidence in the bank’s current financial position. With this dividend decision underscoring management’s confidence, we’ll now examine how it interacts with...
NYSE:SNA
NYSE:SNAMachinery

Snap-on Balances Resilient Sales With Higher Dividend And Ongoing Buybacks

Snap-on (NYSE:SNA) reports resilient sales in a challenging environment, supported by strong product innovation and customer response. The company announces a dividend increase for the sixteenth consecutive year. Snap-on confirms continued share repurchases as part of its capital return program. Snap-on, a long established supplier of tools, equipment, and diagnostics to professional users, is leaning on new products and franchisee feedback as it responds to higher material costs and...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

How Investors Are Reacting To Nordson (NDSN) Strong Q1 Beat And Raised 2026 Sales Guidance

In February 2026, Nordson Corporation reported first-quarter fiscal 2026 results showing sales of US$669.46 million and net income of US$133.38 million, with diluted earnings per share from continuing operations of US$2.38, all higher than the same period a year earlier. Alongside these results, Nordson raised its full-year 2026 sales guidance to a range of US$2.86 billion to US$2.98 billion, signaling increased management confidence backed by strong demand in areas such as semiconductors...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Expands Asia Pacific Research Leadership With Singapore Appointment

Newmark Group (NasdaqGS:NMRK) has appointed Shanting Wong as Head of Research in Singapore. The new role is focused on expanding research and analytics coverage across Asia Pacific markets. The appointment reflects the firm’s push to deepen its global research and advisory capabilities. Newmark Group is a global commercial real estate services firm, and research is a core part of how it supports investors, occupiers, and capital markets clients. By adding senior research leadership in...